Goldman Sachs Reiterates Neutral Rating on Abbvie (ABBV) Ahead of Earnings
Tweet Send to a Friend
Goldman Sachs analyst Asad Haider reiterated a Neutral rating and $223.00 price target on Abbvie (NYSE: ABBV).The analyst comments "Despite ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
